MedPath

Study of the Impact of a Social Robot on Unwanted Loneliness in Elderly People Living in Nursing Homes

Not Applicable
Not yet recruiting
Conditions
Quality of Life
Wellbeing
Social Interaction
Loneliness
Elderly People
Nursing Home Residents
Interventions
Other: Usual Care
Other: Cognitive
Other: Mobility
Other: Social
Other: Relational
Registration Number
NCT06344676
Lead Sponsor
Sara Domenech
Brief Summary

The goal of this clinical trial is to assess the usefulness of social robots reducing unwanted loneliness in persons over 65 living in nursing homes. The main questions it aims to answer are:

* Can social robots reduce unwanted loneliness?

* Can social robots improve quality of live and well-being? The selected centers are organized in several classes of living units. Living units are independent physical spaces with their own common facilities for the persons living in (usually around 15). Living units of the same class gather persons with similar characteristics.

To compare the added value of the robots half of the living units will be allocated to a control group, and the other half to the intervention group.

The persons in living units allocated to the control group will receive the same attentions and care which were receiving before the enrollment in the study, whereas the persons allocated to the intervention group will add a social robot to their usual therapies and activities. Namely participants will do three weekly individual cognitive stimulation sessions of 10 minutes each one, two weekly group mobility sessions of 30 minutes, one monthly conversational group about customs and traditions of 60 minutes, one 10 minutes videoconference per month with their relatives. Furthermore, participants will be able to interact freely with the robot to obtain information about the center (for instance, what is for dinner) and its activities.

The intervention will last 8 weeks. To assess the effectivity, the investigators will assess both groups, before the intervention, at the end of the intervention and 4 weeks after finishing the intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
162
Inclusion Criteria
  • To be 65 years old or older.
  • To live indefinitely for more than 6 months in the participating nursing home (to avoid the effect of the adaptation period).
  • Provide the informed consent.
Exclusion Criteria
  • Impossibility to understand and/or answer the loneliness questionnaire for themselves.
  • To have physical, cognitive or other conditions preventing the use of the robot platform.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Usual CareUsual CareThis group will do the usual therapies and activities that were doing before the enrolment in the study
RobotRelationalThis group will do the usual therapies and activities that were doing before the enrolment in the study plus: * 3 weekly individual cognitive stimulation sessions of 10 minutes. * 2 weekly group mobility sessions of 30 minutes. * 1 monthly group social session of 60 minutes
RobotUsual CareThis group will do the usual therapies and activities that were doing before the enrolment in the study plus: * 3 weekly individual cognitive stimulation sessions of 10 minutes. * 2 weekly group mobility sessions of 30 minutes. * 1 monthly group social session of 60 minutes
RobotCognitiveThis group will do the usual therapies and activities that were doing before the enrolment in the study plus: * 3 weekly individual cognitive stimulation sessions of 10 minutes. * 2 weekly group mobility sessions of 30 minutes. * 1 monthly group social session of 60 minutes
RobotMobilityThis group will do the usual therapies and activities that were doing before the enrolment in the study plus: * 3 weekly individual cognitive stimulation sessions of 10 minutes. * 2 weekly group mobility sessions of 30 minutes. * 1 monthly group social session of 60 minutes
RobotSocialThis group will do the usual therapies and activities that were doing before the enrolment in the study plus: * 3 weekly individual cognitive stimulation sessions of 10 minutes. * 2 weekly group mobility sessions of 30 minutes. * 1 monthly group social session of 60 minutes
Primary Outcome Measures
NameTimeMethod
Lonelinessweeks 0, 8 and 12

Change in the UCLA Loneliness Scale (Version 3). The UCLA Loneliness Scale is a 20-item scale (Russell, 1996) that includes statements (e.g., How often do you feel alone?) rated on a four-point Likert scale ranging from 1 (never) to 4 (always). The total score ranges from 20 to 80. Higher scores indicate greater degrees of loneliness.

Secondary Outcome Measures
NameTimeMethod
Depressive symptomsweeks 0, 8 and 12

Change in 5-item version of Yesavage's Geriatric Depression Scale (GDS-5). This is useful for identify depressive symptoms among elder people. The presence of 2 or more depressive symptoms is indicative of depression. Higher scores indicate greater degrees of depressive symptoms.

Social Supportweeks 0, 8 and 12

Change in the Lubben Social Network Scale (LSNS-6). It is a self-report measure of social engagement including family and friends. The total score is calculated by finding the sum of all items. the score ranges between 0 and 30, with a higher score indicating more social engagement

It is a self-report measure of social engagement including family and friends. The total score is calculated by finding the sum of all items. the score ranges between 0 and 30, with a higher score indicating more social engagement

Well-beingweeks 0, 8 and 12

Change in the World Health Organisation- Five Well-Being Index (WHO-5).The WHO-5 is a short, self-administered measure of well-being over the last two weeks. It consists of five positively worded items that are rated on 6-point Likert scale, ranging from 0 (at no the time) to 5 (all of the time). The total score ranges from 0 to 100, with lower scores indicating worse well-being.

Communicationweeks 0, 8 and 12

Change in the Holden Communication Scale (HCS). This is a scale of 12 items rated from 0 to 4 points completed by a professional based on observation of the person with dementia for a certain period of time. It quantifies, based on the degree of deterioration, those aspects that relate the interrelation of the patient with his immediate environment, and the variables refer to observation, knowledge of reality and communication. A higher score indicates greater impairment.

Quality of life, irrespective of the diseaseweeks 0, 8 and 12

Change in the European Quality of Life 5 Dimensions 5 Level Version (EQ-5D-5L). The EQ-5D-5L can assess patients' quality of life, irrespective of the disease. It covers 5 dimensions of health (mobility, self-care, usual activities, pain or discomfort, and anxiety or depression) with 5 levels of severity in each dimension (no problems, slight problems, moderate problems, severe problems, and unable to perform or extreme problems).

The descriptive system defines 3,125 distinct health-states. Responses can be combined in a form of a 5-digit number (the best state "11111" meaning no problems at any of dimension to the worst state "55555" meaning unable/extreme problems at all five dimensions). The second part of the instrument is a 20 cm visual analog scale (EQ VAS) ranging from 0 (worst health you can imagine) to 100 (best health you can imagine)

Satisfaction with lifeweeks 0, 8 and 12

Change in the Satisfaction With Life Scale (SWLS). A 5-item scale designed to measure global cognitive judgments of one's life satisfaction (not a measure of either positive or negative affect).

Participants indicate how much they agree or disagree with each of the 5 items using a 7-point scale that ranges from 7 strongly agree to 1 strongly disagree. The five responses are summed to produce a total score for the scale. Total scores can, thus, range from a minimum of 5 to a maximum of 35. Higher scores indicate greater degrees of satisfaction with life.

© Copyright 2025. All Rights Reserved by MedPath